Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
June-2018 Volume 15 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2018 Volume 15 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Case Report Open Access

Acute pro‑B‑Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review

  • Authors:
    • Zhi‑Ping Guo
    • Yan‑Hong Tan
    • Jian‑Lan Li
    • Zhi‑Fang Xu
    • Xiu‑Hua Chen
    • Lian‑Rong Xu
  • View Affiliations / Copyright

    Affiliations: Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China
    Copyright: © Guo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 9745-9750
    |
    Published online on: April 20, 2018
       https://doi.org/10.3892/ol.2018.8546
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The development of acute lymphoblastic leukemia (ALL) from myelodysplastic syndrome (MDS) is a very rare event. The current report presents a rare case of a 33‑year‑old man who was diagnosed with MDS with multiple‑lineage dysplasia (MDS‑MLD) that transformed into pro‑B‑ALL. A missense mutation (S1231F) of the additional sex combs like 1, transcriptional regulator gene was identified, which may have a substantial role in the progression, however does not act as an unfavorable prognostic marker. The patient died during induction chemotherapy. The present study further conducted an analysis on 30 patients to determine progression to ALL. Patients were predominantly male (76.7%, 23/30) with a median age of 56 years (3‑90 years). The median time to transformation was 5.5 months (2‑50 months). The most common type of MDS with ALL transformation comprised of MDS‑excess blasts (MDS‑EB; 40%, 12/30), MDS with single‑lineage dysplasia (MDS‑SLD; 30%, 9/30) and MDS with ring sideroblasts (MDS‑RS; 16.7%, 5/30). The majority of the patients transformed to B‑cell (66.7%, 16/24) followed by T‑cell (33.3%, 8/24) ALL. From the 25 cases where data was available, the complete remission rate was 75% (15/20) with ALL‑directed chemotherapy and the median remission duration was 15 months (range 4.5 to 51 months). However, the results indicated that ALL following MDS is characterized by a high rate of early death (20%, 5/25).
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Nimer SD: Myelodysplastic syndromes. Blood. 111:4841–4851. 2008. View Article : Google Scholar : PubMed/NCBI

2 

Visconte V, Selleri C, Maciejewski JP and Tiu RV: Molecular pathogenesis of myelodysplastic syndromes. Transl Med UniSa. 8:19–30. 2014.PubMed/NCBI

3 

Miguel San JF, Hernández JM, González-Sarmiento R, González M, Sánchez I, Orfao A, Cañizo MC and Borrasca López A: Acute leukemia after a primary myelodysplastic syndrome: Immunophenotypic, genotypic, and clinical characteristics. Blood. 78:768–774. 1991.PubMed/NCBI

4 

Janssen JW, Buschle M, Layton M, Drexler HG, Lyons J, van den Berghe H, Heimpel H, Kubanek B, Kleihauer E, Mufti GJ, et al: Clonal analysis of myelodysplastic syndromes: Evidence of multipotent stem cell origin. Blood. 73:248–254. 1989.PubMed/NCBI

5 

Orfao A, Ortuño F, de Santiago M, Lopez A and Miguel San J: Immunophenotyping of acute leukemias and myelodysplastic syndromes. Cytometry A. 58:62–71. 2004. View Article : Google Scholar : PubMed/NCBI

6 

Disperati P, Ichim CV, Tkachuk D, Chun K, Schuh AC and Wells RA: Progression of myelodysplasia to acute lymphoblastic leukaemia: Implications for disease biology. Leuk Res. 30:233–239. 2006. View Article : Google Scholar : PubMed/NCBI

7 

Gelsi-Boyer V, Trouplin V, Adélaïde J, Bonansea J, Cervera N, Carbuccia N, Lagarde A, Prebet T, Nezri M, Sainty D, et al: Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol. 145:788–800. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Argote Alvarez J and Dasanu CA: ASXL1 mutations in myeloid neoplasms: Pathogenetic considerations, impact on clinical outcomes and survival. Curr Med Res Opin. 1–7. 2017.(Epub ahead of print).

9 

Thol F, Friesen I, Damm F, Yun H, Weissinger EM, Krauter J, Wagner K, Chaturvedi A, Sharma A, Wichmann M, et al: Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. J Clin Oncol. 29:2499–2506. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Fisher CL, Pineault N, Brookes C, Helgason CD, Ohta H, Bodner C, Hess JL, Humphries RK and Brock HW: Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia. Blood. 115:38–46. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Vainchenker W, Delhommeau F, Constantinescu SN and Bernard OA: New mutations and pathogenesis of myeloproliferative neoplasms. Blood. 118:1723–1735. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Algarni AA, Akhtari M and Fu K: Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: A case report with review of the literature. Case Rep Hematol. 2012:2075372012.PubMed/NCBI

13 

Gupta V and Bhatia B: Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia in a child. Indian J Hematol Blood Transfus. 26:111–113. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Cimino G, Elia L, Mancini M, Annino L, Anaclerico B, Fazi P, Vitale A, Specchia G, Di Raimondo F, Recchia A, et al: Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: Absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome. Blood. 102:2014–2020. 2003. View Article : Google Scholar : PubMed/NCBI

15 

Escudier SM, Albitar M, Robertson LE, Andreeff M, Pierce S and Kantarjian HM: Acute lymphoblastic leukemia following preleukemic syndromes in adults. Leukemia. 10:473–477. 1996.PubMed/NCBI

16 

Fisher CL, Randazzo F, Humphries RK and Brock HW: Characterization of Asxl1, a murine homolog of Additional sex combs, and analysis of the Asx-like gene family. Gene. 369:109–118. 2006. View Article : Google Scholar : PubMed/NCBI

17 

Sato N, Nakazato T, Kizaki M, Ikeda Y and Okamoto S: Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: A case report and review of the literature. Int J Hematol. 79:147–151. 2004. View Article : Google Scholar : PubMed/NCBI

18 

Follows GA, Owen RG, Ashcroft AJ and Parapia LA: Eosinophilic myelodysplasia transforming to acute lymphoblastic leukaemia. J Clin Pathol. 52:388–389. 1999. View Article : Google Scholar : PubMed/NCBI

19 

Inoshita T: Acute lymphoblastic leukemia following myelodysplastic syndrome. Am J Clin Pathol. 84:233–237. 1985. View Article : Google Scholar : PubMed/NCBI

20 

Kohno T, Amenomori T, Atogami S, Sasagawa I, Nakamura H, Kuriyama K and Tomonaga M: Progression from myelodysplastic syndrome to acute lymphoblastic leukaemia with Philadelphia chromosome and p190 BCR-ABL transcript. Br J Haematol. 93:389–391. 1996. View Article : Google Scholar : PubMed/NCBI

21 

Bonati A, Delia D and Starcich R: Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype. Br J Haematol. 64:487–491. 1986. View Article : Google Scholar : PubMed/NCBI

22 

Ascensao JL, Kay NE, Wright JJ, Arthur D, Finkel B, Rydell R and Kaplan ME: Lymphoblastic transformation of myelodysplastic syndrome. Am J Hematol. 22:431–434. 1986. View Article : Google Scholar : PubMed/NCBI

23 

Rossbach HC, Sutcliffe MJ, Chamizo W, Haag MM, Grana NH, Washington KR and Barbosa JL: Pre-B acute lymphoblastic leukemia in a 3-year-old boy with pre-acute myelogenous leukemia myelodysplastic syndrome: Cytogenetic evidence of common early progenitor cell ontogeny. J Pediatr Hematol Oncol. 20:347–352. 1998. View Article : Google Scholar : PubMed/NCBI

24 

Bader-Meunier B, Miélot F, Tchernia G, Buisine J, Delsol G, Duchayne E, Lemerle S, Leverger G, de Lumley L and Manel AM: Myelodysplastic syndromes in childhood: Report of 49 patients from a French multicentre study. French society of paediatric haematology and immunology. Br J Haematol. 92:344–350. 1996. View Article : Google Scholar : PubMed/NCBI

25 

Abruzzese E, Buss D, Rainer R, Pettenati MJ and Rao PN: Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukemia: A case report and cell lineage study. Ann Hematol. 73:35–38. 1996. View Article : Google Scholar : PubMed/NCBI

26 

Ikeda T, Sato K, Yamashita T, Kanai Y, Kuwada N, Matsumura T, Nakamura Y, Kimura F and Motoyoshi K: Burkitt's acute lymphoblastic leukaemia transformation after myelodysplastic syndrome. Br J Haematol. 115:69–71. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Hussein KK, Salem Z, Bottomley SS and Livingston RB: Acute leukemia in idiopathic sideroblastic anemia: Response to combination chemotherapy. Blood. 59:652–656. 1982.PubMed/NCBI

28 

Barton JC, Conrad ME and Parmley RT: Acute lymphoblastic leukemia in idiopathic refractory sideroblastic anemia: Evidence for a common lymphoid and myeloid progenitor cell. Am J Hematol. 9:109–115. 1980. View Article : Google Scholar : PubMed/NCBI

29 

Naithani R, Kumar R, Saxena R and Mahapatra M: Transformation of myelodysplastic syndrome to T-cell acute lymphoblastic leukemia in a young adult. Pediatr Hematol Oncol. 26:100–102. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Berneman ZN, Van Bockstaele D, De Meyer P, Van der Planken M, Vertessen F, De Bock R and Peetermans ME: A myelodysplastic syndrome preceding acute lymphoblastic leukaemia. Br J Haematol. 60:353–354. 1985. View Article : Google Scholar : PubMed/NCBI

31 

Lima CS, de Souza CA, Cardinalli IA and Lorand-Metze I: Lymphoblastic transformation of myelodysplastic syndrome. Sao Paulo Med J. 115:1508–1512. 1997. View Article : Google Scholar : PubMed/NCBI

32 

Goel R, Kumar R and Bakhshi S: Transformation of childhood MDS-refractory anemia to acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 29:725–727. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Nagler A, Brenner B and Tatarsky I: Secondary refractory anemia with excess of blasts in transformation terminating as acute lymphoblastic leukemia. Acta Haematol. 76:164–165. 1986. View Article : Google Scholar : PubMed/NCBI

34 

Pereira AM, de Castro Tavares J, Santos EG, Perloiro MC and Catovsky D: T lymphoblastic transformation of refractory anaemia with excess of blasts. Clin Lab Haematol. 7:89–95. 1985. View Article : Google Scholar : PubMed/NCBI

35 

Pajor L, Matolcsy A, Vass JA, Méhes G, Marton E, Szabó F and Iványi JL: Phenotypic and genotypic analyses of blastic cell population suggest that pure B-lymphoblastic leukemia may arise from myelodysplastic syndrome. Leuk Res. 22:13–17. 1998. View Article : Google Scholar : PubMed/NCBI

36 

Koh YR, Cho EH, Park SS, Park MY, Lee SM, Kim IS and Lee EY: A rare case of transformation of childhood myelodysplastic syndrome to acute lymphoblastic leukemia. Ann Lab Med. 33:130–135. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Guo ZP, Tan YH, Li JL, Xu ZF, Chen XH and Xu LR: Acute pro‑B‑Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review. Oncol Lett 15: 9745-9750, 2018.
APA
Guo, Z., Tan, Y., Li, J., Xu, Z., Chen, X., & Xu, L. (2018). Acute pro‑B‑Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review. Oncology Letters, 15, 9745-9750. https://doi.org/10.3892/ol.2018.8546
MLA
Guo, Z., Tan, Y., Li, J., Xu, Z., Chen, X., Xu, L."Acute pro‑B‑Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review". Oncology Letters 15.6 (2018): 9745-9750.
Chicago
Guo, Z., Tan, Y., Li, J., Xu, Z., Chen, X., Xu, L."Acute pro‑B‑Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review". Oncology Letters 15, no. 6 (2018): 9745-9750. https://doi.org/10.3892/ol.2018.8546
Copy and paste a formatted citation
x
Spandidos Publications style
Guo ZP, Tan YH, Li JL, Xu ZF, Chen XH and Xu LR: Acute pro‑B‑Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review. Oncol Lett 15: 9745-9750, 2018.
APA
Guo, Z., Tan, Y., Li, J., Xu, Z., Chen, X., & Xu, L. (2018). Acute pro‑B‑Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review. Oncology Letters, 15, 9745-9750. https://doi.org/10.3892/ol.2018.8546
MLA
Guo, Z., Tan, Y., Li, J., Xu, Z., Chen, X., Xu, L."Acute pro‑B‑Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review". Oncology Letters 15.6 (2018): 9745-9750.
Chicago
Guo, Z., Tan, Y., Li, J., Xu, Z., Chen, X., Xu, L."Acute pro‑B‑Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review". Oncology Letters 15, no. 6 (2018): 9745-9750. https://doi.org/10.3892/ol.2018.8546
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team